CXC chemokine receptor 1 predicts postoperative prognosis and chemotherapeutic benefits for TNM II and III resectable gastric cancer patients

BACKROUND: Abnormal expression of CXC chemokine receptor 1 (CXCR1) has shown the ability to promote tumor angiogensis, invasion and metastasis in several cancers. The purpose of our curret study is to discover the clinical prognostic significance of CXCR1 in resectable gastric cancer. METHODS: 330 g...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Oncotarget
Main Authors: Cao, Yifan, Liu, Hao, Zhang, Heng, Lin, Chao, Li, Ruochen, Wu, Songyang, Li, He, He, Hongyong, Zhang, Weijuan, Xu, Jiejie
Formato: Artigo
Idioma:Inglês
Publicado em: Impact Journals LLC 2016
Assuntos:
Clinical Research Paper
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC5386765/
https://ncbi.nlm.nih.gov/pubmed/27780937
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.18632/oncotarget.12815
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados